Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.
A large study applies advanced machine learning to identify shared risk factors and predictors of disease onset in patients with epilepsy and depression.